Quick Answer
International Stem Cell CORP reported Research And Development Expense of $684.0 thousand for the year ending 2025.
- International Stem Cell CORP showed an increase of +4.1% in Research And Development Expense from 2024 to 2025.
- This data is from International Stem Cell CORP's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $721.0 thousand | Q2 2013: $974.0 thousand | Q3 2013: $932.0 thousand | Q1 2014: $958.0 thousand | Q2 2014: $1.41 million | Q3 2014: $1.39 million | Q1 2015: $1.12 million | Q2 2015: $567.0 thousand | Q3 2015: $508.0 thousand | Q1 2016: $579.0 thousand | Q2 2016: $852.0 thousand | Q3 2016: $679.0 thousand | Q1 2017: $645.0 thousand | Q2 2017: $739.0 thousand | Q3 2017: $670.0 thousand | Q1 2018: $811.0 thousand | Q2 2018: $452.0 thousand | Q3 2018: $616.0 thousand | Q1 2019: $653.0 thousand | Q2 2019: $268.0 thousand | Q3 2019: $79.0 thousand | Q1 2020: $303.0 thousand | Q2 2020: $200.0 thousand | Q3 2020: $255.0 thousand | Q1 2021: $215.0 thousand | Q2 2021: $113.0 thousand | Q3 2021: $165.0 thousand | Q1 2022: $137.0 thousand | Q2 2022: $83.0 thousand | Q3 2022: $147.0 thousand | Q1 2023: $145.0 thousand | Q2 2023: $45.0 thousand | Q3 2023: $155.0 thousand | Q1 2024: $177.0 thousand | Q2 2024: $83.0 thousand | Q3 2024: $187.0 thousand | Q1 2025: $187.0 thousand | Q2 2025: $162.0 thousand | Q3 2025: $158.0 thousand.
- Over the full 16 years of available data (2010 to 2025), International Stem Cell CORP's Research And Development Expense has declined by 79.7%.
- Historical annual values: Fiscal year 2025: $684.0 thousand | Fiscal year 2024: $657.0 thousand | Fiscal year 2023: $511.0 thousand | Fiscal year 2022: $492.0 thousand | Fiscal year 2021: $695.0 thousand | Fiscal year 2020: $988.0 thousand | Fiscal year 2019: $1.39 million | Fiscal year 2018: $2.40 million | Fiscal year 2017: $2.66 million | Fiscal year 2016: $2.86 million | Fiscal year 2015: $2.71 million | Fiscal year 2014: $5.39 million | Fiscal year 2013: $3.56 million | Fiscal year 2012: $3.60 million | Fiscal year 2011: $4.43 million | Fiscal year 2010: $3.37 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: